WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 240

Legislative bill overview

HB 240 is a Hawaii bill focused on overdose prevention measures, though the specific provisions are not detailed in the available information. Based on the referrals to Health (HLT/HSH), Judiciary (JHA), and Finance (FIN) committees, the bill likely addresses drug-related public health interventions, possibly including harm reduction strategies, naloxone access, or substance use disorder treatment programs.

Why is this important

Overdose deaths remain a significant public health crisis nationwide, with fentanyl-related deaths rising sharply. Hawaii, like other states, has experienced increases in overdose fatalities, making overdose prevention legislation relevant to reducing mortality and improving community health outcomes.

Potential points of contention

  • Harm reduction vs. enforcement: Disagreement may exist over whether the bill prioritizes treatment/harm reduction or enforcement-based approaches to drug use
  • Implementation costs and funding: Finance committee referral suggests budget concerns; determining who bears costs (state, counties, healthcare systems) could be contentious
  • Scope of access: If the bill expands naloxone distribution, disagreement may arise over which populations receive it and whether pharmacies or law enforcement should distribute it

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.